Microbot Medical Inc. (MBOT): Price and Financial Metrics


Microbot Medical Inc. (MBOT): $5.02

-0.15 (-2.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MBOT Stock Price Chart Interactive Chart >

Price chart for MBOT

MBOT Price/Volume Stats

Current price $5.02 52-week high $9.60
Prev. close $5.17 52-week low $4.31
Day low $5.02 Volume 1,700
Day high $5.13 Avg. volume 86,130
50-day MA $5.44 Dividend yield N/A
200-day MA $6.05 Market Cap 35.68M

Microbot Medical Inc. (MBOT) Company Bio


Microbot Medical Inc. operates as a medical device company. The Company specializes in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Microbot Medical offers its services in the United States.


MBOT Latest News Stream


Event/Time News Detail
Loading, please wait...

MBOT Latest Social Stream


Loading social stream, please wait...

View Full MBOT Social Stream

Latest MBOT News From Around the Web

Below are the latest news stories about Microbot Medical Inc that investors may wish to consider to help them evaluate MBOT as an investment opportunity.

Thinking about buying stock in Exterran Corp, Microbot Medical, Nordstrom, Telefonica S.A., or Assertio Holdings?

NEW YORK , Jan. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXTN, MBOT, JWN, TEF, and ASRT. Full story available on Benzinga.com

Benzinga | January 24, 2022

Short Squeeze Stocks: PIXY, MBOT and 3 Others Experts Think Are Ready to Pop

“Blood bath” would be an appropriate term to use for today’s price action in the markets. This goes double for highly speculative growth stocks. However, investors looking for silver linings among today’s otherwise indiscriminate declines may notice a few stocks are doing well. Among some of the best-performing tickers today are a number of short squeeze stocks that are picking up momentum. Source: Alextype/Shutterstock.com By and large, most large-cap short squeeze stocks remain under pressure.

Yahoo | January 24, 2022

Microbot Medical, CymaBay lead healthcare gainers; Aptorum, G Medical among losers

Microbot Medical (MBOT) +10%. CymaBay Therapeutics (CBAY) +9%. Aptorum (APM) -13%. G Medical Innovations (GMVD) -11%.

Seeking Alpha | January 21, 2022

Short Squeeze Stocks: ISIG, PIXY and 3 Others Experts Think Are Ready to Pop

These five top short squeeze stocks are worth a close look from retail investors looking for opportunities in an otherwise down market.

Chris MacDonald on InvestorPlace | January 18, 2022

Microbot Medical''s Stryker Collaboration Makes This An Intriguing High Flier

No summary available.

Seeking Alpha | January 6, 2022

Read More 'MBOT' Stories Here

MBOT Price Returns

1-mo N/A
3-mo -19.94%
6-mo -33.07%
1-year -36.62%
3-year -2.52%
5-year -76.43%
YTD -33.07%
2021 8.85%
2020 -32.25%
2019 491.28%
2018 -88.76%
2017 -83.28%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5254 seconds.